Sensible Biotechnologies
Sensible Biotechnologies is pioneering a cell-based platform for the design and manufacturing of mRNA therapeutics. Their proprietary closed-loop AI-powered design and optimization platform models RNA folding from raw sequence to stable conformation, leveraging NVIDIA technology including BioNeMo framework and NIM microservices on the NVIDIA DGX Cloud platform with NVIDIA Hopper GPUs. This integration enables them to achieve significantly faster mRNA optimization cycles, reducing them from 15 days to just one. Their platform creates pure, low-immunogenicity mRNA, unlocking new therapeutic areas for conditions such as cancer and rare diseases, offering a safer, effective, and affordable alternative to traditional in vitro transcription methods.
Sensible Biotechnologies
Sensible Biotechnologies is pioneering a cell-based platform for the design and manufacturing of mRNA therapeutics. Their proprietary closed-loop AI-powered design and optimization platform models RNA folding from raw sequence to stable conformation, leveraging NVIDIA technology including BioNeMo framework and NIM microservices on the NVIDIA DGX Cloud platform with NVIDIA Hopper GPUs. This integration enables them to achieve significantly faster mRNA optimization cycles, reducing them from 15 days to just one. Their platform creates pure, low-immunogenicity mRNA, unlocking new therapeutic areas for conditions such as cancer and rare diseases, offering a safer, effective, and affordable alternative to traditional in vitro transcription methods.